Atlas Trials

An Open-Label Extension Study of NGX-4010 for the Treatment of Neuropathic Pain

Clinical trial NCT00089557 · TERMINATED

Trial details

NCT number
NCT00089557
Sponsor
NeurogesX
Status
TERMINATED
Phase
Phase 2
Study type
INTERVENTIONAL
Herpes ZosterNeuralgiaPainHIV InfectionsPeripheral Nervous System DiseasesDiabetic NeuropathiesDiabetes MellitusPolyneuropathies

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.